Smart inhalers are clip-on sensors, also known as connected inhalers, which are attached to the traditional inhalers. They are used to track the medication, dosage, and time taken for each dose. Linked wirelessly to the cloud, smart inhalers are a part of Internet of Things, thus providing correct use of the medication, improved adherence to the inhaler, and better health outcomes. Research Beam Model: Research Beam Product ID: 731272 5370 USD New
Smart Inhalers Market by Product (Inhalers and Nebulizers, Dry Powder Inhalers (DPIs), Metered Dose Inhalers (MDIs)), Indication (Asthma and COPD), End User (Patients and R and D) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022
 
 

Smart Inhalers Market by Product (Inhalers and Nebulizers, Dry Powder Inhalers (DPIs), Metered Dose Inhalers (MDIs)), Indication (Asthma and COPD), End User (Patients and R and D) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

  • Category : Medical Devices
  • Published On : September   2016
  • Pages : 202
  • Publisher : Allied Market Research
 
 
 

Smart inhalers are clip-on sensors, also known as connected inhalers, which are attached to the traditional inhalers. They are used to track the medication, dosage, and time taken for each dose. Linked wirelessly to the cloud, smart inhalers are a part of “Internet of Things,” thus providing correct use of the medication, improved adherence to the inhaler, and better health outcomes. Doctors and patients can easily benefit from the use of smart inhalers as they monitor the dosage and provide reminders at the time of the dose, which can be recorded for understanding the patient’s daily routine.

The world smart inhalers market is analyzed under three different scenarios, namely, moderate growth, rapid growth, and diminishing growth. Under the moderate growth scenario, smart inhalers market is estimated to reach $191 million by 2022, growing at a CAGR of 63.3% during 2016 to 2022. Market growth is attributed to the rapid increase in the incidence of respiratory diseases, rise in air pollution, and growth in healthcare burden, due to higher cases of asthma and COPD. In addition, expected increase in adherence to smart inhalers is another major factor for the growth of smart inhalers market. However, limited availability of smart inhalers, high cost of asthma and COPD treatment, and resistance towards adoption of smart inhalers are expected to hinder the market growth.

The market is segmented on the basis of product, indication, end user, and geography. By product, it is segmented into inhalers and nebulizers. Inhalers dominates the market, which is further divided into dry powder inhalers (DPIs) and metered dose inhalers (MDIs). Based on indication, smart inhalers are bifurcated into asthma and COPD. On the basis of end user, it is divided into patients and R&D. In terms of geography, the market is analyzed into North America, Europe, Asia-Pacific, and LAMEA.

North America was the leading revenue-generating region, whereas Asia-Pacific is projected to grow at the highest CAGR of 65.3%, owing to rise in demand for smart inhalers and increase in COPD and asthma cases.

Companies have adopted product approval and clinical trials as their key development strategies. Increase in focus on clinical trials is mainly for the development of innovative technologies in the field of smart inhalers. In March 2016, Adherium received a product approval to sell its “SmartTurbo” and “SmartTouch” devices in Canada, thereby expanding its product portfolio.

Key players operating in the market include:

  • Adherium Limited
  • Teva Pharmaceutical Industries Ltd. (Gecko Health Innovations)
  • Propeller Health
  • Cohero Health, LLC
  • OPKO Health, Inc. (Inspiro Medical Ltd.)
  • GlaxoSmithKline plc
  • Novartis AG
  • AstraZeneca plc
  • Boehringer Ingelheim GmbH
  • Vectura Group plc

KEY BENEFITS FOR STAKEHOLDERS:

  • The report provides an in-depth analysis of the estimated revenues generated by smart inhalers as well as major geographies during the forecast period.
  • The report presents three different market scenarios for smart inhalers, both for value and volume, based on rapid growth, diminishing growth, and moderate growth scenarios.
  • Quantitative analysis of the current market and estimations from 2016 to 2022 is presented to help the manufacturers of smart inhalers to analyze the market.
  • Entire projections presented in the report highlight the market potential, both in terms of value and volume.
  • The report conducts extensive analysis of the market by closely following key product positioning and monitoring the top contenders within the market framework.

KEY MARKET SEGMENTS:

By Product

  • Inhalers
  • Dry Powder Inhalers (DPIs)
  • Metered Dose Inhalers (MDIs)
  • Nebulizers

By Indication

  • Asthma
  • COPD

By End User

  • Patients
  • R&D

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of LAMEA

CHAPTER 1 INTRODUCTION

1.1 Report Description
1.2 Key Benefits
1.3 Key Market Segments
1.4 Research Methodology

1.4.1 Secondary Research
1.4.2 Primary Research
1.4.3 Analyst Tools and Models

CHAPTER 2 EXECUTIVE SUMMARY

2.1 CXO Perspective

CHAPTER 3 MARKET OVERVIEW

3.1 Market Definition and Scope
3.2 Key Findings

3.2.1 Top Winning Strategies
3.2.2 Top Investment Pockets

3.3 Porters Five Forces Analysis

3.3.1 Bargaining Power of Suppliers
3.3.2 Bargaining Power of Buyers
3.3.3 Threat of Substitutes
3.3.4 Threat of New Entrants
3.3.5 Intensity of Competitive Rivalry

3.4 Top Player Positioning, 2015
3.5 Clinical Trials
3.6 Product Portfolio
3.7 Market Dynamics

3.7.1 Drivers

3.7.1.1 Global increase in air pollution
3.7.1.2 Increase in population susceptible to indoor air pollutants
3.7.1.3 Increasing prevalence of COPD and asthma globally
3.7.1.4 Expected increase in adherence to smart inhalers
3.7.1.5 Increasing collaboration between pharmaceutical companies and smart inhaler manufacturers
3.7.1.6 Rising incidences of chronic conditions

3.7.2 Restraints

3.7.2.1 Misusing data and data privacy
3.7.2.2 Availability of smart inhalers
3.7.2.3 Overall high cost of asthma and COPD treatment
3.7.2.4 Resistance towards adoption of smart inhalers

3.7.3 Opportunities

3.7.3.1 Increased focus towards advanced treatment protocols
3.7.3.2 Significant unmet need in respiratory care
3.7.3.3 Increased awareness to reduce healthcare costs
3.7.3.4 Opportunities in emerging economies

CHAPTER 4 SMART INHALERS MARKET, BY PRODUCT, 2014-2022

4.1 Overview

4.1.1 Market Size and Forecast

4.2 Inhalers

4.2.1 Key Market Trends
4.2.2 Growth Factors and Opportunities
4.2.3 Market Size and Forecast
4.2.4 Dry Powder Inhalers (DPIs)
4.2.5 Metered Dose Inhalers (MDIs)

4.3 Nebulizers

4.3.1 Key Market Trends
4.3.2 Growth Factors and Opportunities
4.3.3 Market Size and Forecast

CHAPTER 5 SMART INHALERS MARKET, BY INDICATION, 2014-2022

5.1 Overview

5.1.1 Market Size and Forecast

5.2 Asthma

5.2.1 Market Size and Forecast

5.3 COPD

5.3.1 Market Size and Forecast

CHAPTER 6 SMART INHALERS MARKET, BY END USER, 2014-2022

6.1 Overview

6.1.1 Market Size and Forecast

6.2 Patients

6.2.1 Market Size and Forecast

6.3 R&D

6.3.1 Market Size and Forecast

CHAPTER 7 SMART INHALERS MARKET, BY GEOGRAPHY, 2014-2022

7.1 Overview

7.1.1 Market Size and Forecast

7.2 North America

7.2.1 Key Market Trends
7.2.2 Growth Factors and Opportunities
7.2.3 Market Size and Forecast

7.2.3.1 U.S.: Market Size and Forecast
7.2.3.2 Canada: Market Size and Forecast
7.2.3.3 Mexico: Market Size and Forecast

7.3 Europe

7.3.1 Key Market Trends
7.3.2 Growth Factors and Opportunities
7.3.3 Market Size and Forecast

7.3.3.1 Germany: Market Size and Forecast
7.3.3.2 UK: Market Size and Forecast
7.3.3.3 France: Market Size and Forecast
7.3.3.4 Italy: Market Size and Forecast
7.3.3.5 Russia: Market Size and Forecast

7.4 Asia-Pacific

7.4.1 Key Market Trends
7.4.2 Growth Factors and Opportunities
7.4.3 Market Size and Forecast

7.4.3.1 Japan: Market Size and Forecast
7.4.3.2 China: Market Size and Forecast
7.4.3.3 India: Market Size and Forecast
7.4.3.4 Australia: Market Size and Forecast
7.4.3.5 Rest of Asia-Pacific: Market Size and Forecast

7.5 LAMEA (Latin America, Middle East, and Africa)

7.5.1 Key Market Trends
7.5.2 Growth Factors and Opportunities
7.5.3 Market Size and Forecast

7.5.3.1 Brazil: Market Size and Forecast
7.5.3.2 Turkey: Market Size and Forecast
7.5.3.3 Saudi Arabia: Market Size and Forecast
7.5.3.4 UAE: Market Size and Forecast
7.5.3.5 Rest of Lamea: Market Size and Forecast

CHAPTER 8 COMPANY PROFILES

8.1 Adherium Limited

8.1.1 Company Overview
8.1.2 Company Snapshot
8.1.3 Operating Business Segments
8.1.4 Business Performance
8.1.5 Key Strategic Moves and Developments

8.2 Teva Pharmaceutical Industries Ltd. (Gecko Health Innovations)

8.2.1 Company Overview
8.2.2 Company Snapshot
8.2.3 Operating Business Segments
8.2.4 Business Performance
8.2.5 Key Strategic Moves and Developments

8.3 Propeller Health

8.3.1 Company Overview
8.3.2 Company Snapshot
8.3.3 Operating Business Segments
8.3.4 Business Performance
8.3.5 Key Strategic Moves and Developments

8.4 Cohero Health, LLC

8.4.1 Company Overview
8.4.2 Company Snapshot
8.4.3 Operating Business Segments
8.4.4 Business Performance
8.4.5 Key Strategic Moves and Developments

8.5 OPKO Health, Inc. (Inspiro Medical Ltd.)

8.5.1 Company Overview
8.5.2 Company Snapshot
8.5.3 Operating Business Segments
8.5.4 Business Performance
8.5.5 Key Strategic Moves and Developments

8.6 GlaxoSmithKline plc

8.6.1 Company Overview
8.6.2 Operating Business Segments
8.6.3 Business Performance
8.6.4 Key Strategic Moves and Developments

8.7 Novartis AG

8.7.1 Company Overview
8.7.2 Operating Business Segments
8.7.3 Business Performance
8.7.4 Key Strategic Moves and Developments

8.8 AstraZeneca plc

8.8.1 Company Overview
8.8.2 Operating Business Segments
8.8.3 Business Performance
8.8.4 Key Strategic Moves and Developments

8.9 Boehringer Ingelheim GmbH

8.9.1 Company Overview
8.9.2 Operating Business Segments
8.9.3 Business Performance
8.9.4 Key Strategic Moves and Developments

8.10 Vectura Group plc

8.10.1 Company Overview
8.10.2 Company Snapshot
8.10.3 Operating Business Segments
8.10.4 Business Performance
8.10.5 Key Strategic Moves and Developments

List of Figures

FIG. 1 PRIMARY RESPONDENTS: % SPLIT
FIG. 2 SMART INHALERS MARKET: SEGMENTATION
FIG. 3 TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION
FIG. 4 TOP WINNING STRATEGIES: NATURE & TYPE
FIG. 5 TYPES OF STRATEGIES DISTRIBUTION
FIG. 6 DETAILED STRUCTURE OF COMPANIES AND NATURE OF STRATEGIES
FIG. 7 DETAILED STRUCTURE OF COMPANIES AND TYPE OF STRATEGIES
FIG. 8 TOP INVESTMENT POCKETS: WORLD SMART INHALERS, BY REGION
FIG. 9 PORTERS FIVE FORCES ANALYSIS
FIG. 10 TOP PLAYER POSITIONING, 2015
FIG. 11 TOP IMPACTING FACTORS: SMART INHALERS MARKET, 20152022
FIG. 12 ASTHMA: MAJOR INFLUENCING FACTORS
FIG. 13 ASTHMA: ECONOMIC BURDEN
FIG. 14 GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE (GOLD) CLASSIFICATION OF COPD
FIG. 15 COPD: MAJOR CAUSES
FIG. 16 U.S.: SMART INHALERS MARKET SIZE, 20142022 ($000)
FIG. 17 U.S.: SMART INHALERS MARKET SIZE, 20142022 (TOTAL UNITS)
FIG. 18 CANADA: SMART INHALERS MARKET SIZE, 20142022 ($000)
FIG. 19 CANADA: SMART INHALERS MARKET SIZE, 20142022 (TOTAL UNITS)
FIG. 20 MEXICO: SMART INHALERS MARKET SIZE, 20142022 ($000)
FIG. 21 MEXICO: SMART INHALERS MARKET SIZE, 20142022 (TOTAL UNITS)
FIG. 22 GERMANY: SMART INHALERS MARKET SIZE, 20142022 ($000)
FIG. 23 GERMANY: SMART INHALERS MARKET SIZE, 20142022 (TOTAL UNITS)
FIG. 24 UK: SMART INHALERS MARKET SIZE, 20142022 ($000)
FIG. 25 UK: SMART INHALERS MARKET SIZE, 20142022 (TOTAL UNITS)
FIG. 26 FRANCE: SMART INHALERS MARKET SIZE, 20142022 ($000)
FIG. 27 FRANCE: SMART INHALERS MARKET SIZE, 20142022 (TOTAL UNITS)
FIG. 28 ITALY: SMART INHALERS MARKET SIZE, 20142022 ($000)
FIG. 29 ITALY: SMART INHALERS MARKET SIZE, 20142022 (TOTAL UNITS)
FIG. 30 RUSSIA: SMART INHALERS MARKET SIZE, 20142022 ($000)
FIG. 31 RUSSIA: SMART INHALERS MARKET SIZE, 20142022 (TOTAL UNITS)
FIG. 32 REST OF EUROPE: MARKET SIZE AND FORECAST
FIG. 33 REST OF EUROPE: SMART INHALERS MARKET SIZE, 20142022 ($000)
FIG. 34 REST OF EUROPE: SMART INHALERS MARKET SIZE, 20142022 (TOTAL UNITS)
FIG. 35 JAPAN: SMART INHALERS MARKET SIZE, 20142022 ($000)
FIG. 36 JAPAN: SMART INHALERS MARKET SIZE, 20142022 (TOTAL UNITS)
FIG. 37 CHINA: SMART INHALERS MARKET SIZE, 20142022 ($000)
FIG. 38 CHINA: SMART INHALERS MARKET SIZE, 20142022 (TOTAL UNITS)
FIG. 39 INDIA: SMART INHALERS MARKET SIZE, 20142022 ($000)
FIG. 40 INDIA: SMART INHALERS MARKET SIZE, 20142022 (TOTAL UNITS)
FIG. 41 AUSTRALIA: SMART INHALERS MARKET SIZE, 20142022 ($000)
FIG. 42 AUSTRALIA: SMART INHALERS MARKET SIZE, 20142022 (TOTAL UNITS)
FIG. 43 REST OF ASIA-PACIFIC: SMART INHALERS MARKET SIZE, 20142022 ($000)
FIG. 44 REST OF ASIA-PACIFIC: SMART INHALERS MARKET SIZE, 20142022 (TOTAL UNITS)
FIG. 45 BRAZIL: SMART INHALERS MARKET SIZE, 20142022 ($000)
FIG. 46 BRAZIL: SMART INHALERS MARKET SIZE, 20142022 (TOTAL UNITS)
FIG. 47 TURKEY: SMART INHALERS MARKET SIZE, 20142022 ($000)
FIG. 48 TURKEY: SMART INHALERS MARKET SIZE, 20142022 (TOTAL UNITS)
FIG. 49 SAUDI ARABIA: SMART INHALERS MARKET SIZE, 20142022 ($000)
FIG. 50 SAUDI ARABIA: SMART INHALERS MARKET SIZE, 20142022 (TOTAL UNITS)
FIG. 51 UAE: SMART INHALERS MARKET SIZE, 20142022 ($000)
FIG. 52 UAE: SMART INHALERS MARKET SIZE, 20142022 (TOTAL UNITS)
FIG. 53 REST OF LAMEA: SMART INHALERS MARKET SIZE, 20142022 ($000)
FIG. 54 REST OF LAMEA: SMART INHALERS MARKET SIZE, 20142022 (TOTAL UNITS)
FIG. 55 ADHERIUM: NET REVENUE, 20142015 ($MILLION)
FIG. 56 ADHERIUM: STRATEGY SHARE, 20152016 (%)
FIG. 57 TEVA: REVENUE, 20132015 ($MILLION)
FIG. 58 TEVA: REVENUE, BY PRODUCT TYPE, 2015 (%)
FIG. 59 PROPELLER HEALTH: STRATEGY SHARE, 20152016 (%)
FIG. 60 COHERO HEALTH: STRATEGY SHARE, 20142016 (%)
FIG. 61 OPKO HEALTH: REVENUE, 20132015 ($MILLION)
FIG. 62 OPKO HEALTH: REVENUE, BY SEGMENT, 2015 (%)
FIG. 63 OPKO HEALTH: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 64 OPKO HEALTH: STRATEGY SHARE, 20132014 (%)
FIG. 65 GSK: REVENUE, 20132015 ($MILLION)
FIG. 66 GSK: REVENUE, BY SEGMENT, 2015 (%)
FIG. 67 GSK: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 68 GSK: STRATEGY SHARE, 20132015 (%)
FIG. 69 NOVARTIS: REVENUE, 20132015 ($MILLION)
FIG. 70 NOVARTIS: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 71 NOVARTIS: REVENUE, BY SEGMENT, 2015 (%)
FIG. 72 NOVARTIS: STRATEGY SHARE, 20132015 (%)
FIG. 73 ASTRAZENECA: REVENUE, 20132015 ($MILLION)
FIG. 74 ASTRAZENECA: REVENUE, BY SEGMENT, 2015 (%)
FIG. 75 ASTRAZENECA: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 76 ASTRAZENECA: STRATEGY SHARE, 20142016 (%)
FIG. 77 BOEHRINGER INGELHEIM: REVENUE, 20132015 ($MILLION)
FIG. 78 BOEHRINGER INGELHEIM: REVENUE, BY SEGMENT, 2015 (%)
FIG. 79 BOEHRINGER INGELHEIM: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 80 BOEHRINGER INGELHEIM: STRATEGY SHARE, 20142016 (%)
FIG. 81 VECTURA: REVENUE, 20132015 ($MILLION)
FIG. 82 VECTURA: REVENUE, BY GEOGRAPHY, 2015 (%)

List of Tables

TABLE 1 CLINICAL TRIALS: SMART INHALERS
TABLE 2 SMART INHALERS MARKET, BY PRODUCT, 20142022 ($000), MODERATE SCENARIO
TABLE 3 SMART INHALERS MARKET, BY PRODUCT, 20142022 ($000), DIMINISHING SCENARIO
TABLE 4 SMART INHALERS MARKET, BY PRODUCT, 20142022 ($000), RAPID SCENARIO
TABLE 5 SMART INHALERS MARKET, BY PRODUCT, 20142022 (TOTAL UNITS), MODERATE SCENARIO
TABLE 6 SMART INHALERS MARKET, BY PRODUCT, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO
TABLE 7 SMART INHALERS MARKET, BY PRODUCT, 20142022 (TOTAL UNITS), RAPID SCENARIO
TABLE 8 INHALERS MARKET, BY PRODUCT, 20142022 ($000), MODERATE SCENARIO
TABLE 9 INHALERS MARKET, BY PRODUCT, 20142022 ($000), DIMINISHING SCENARIO
TABLE 10 INHALERS MARKET, BY PRODUCT, 20142022 ($000), RAPID SCENARIO
TABLE 11 INHALERS MARKET, BY GEOGRAPHY, 20142022 ($000), MODERATE SCENARIO
TABLE 12 INHALERS MARKET, BY GEOGRAPHY, 20142022 ($000), DIMINISHING SCENARIO
TABLE 13 INHALERS MARKET, BY GEOGRAPHY, 20142022 ($000), RAPID SCENARIO
TABLE 14 INHALERS MARKET, BY PRODUCT, 20142022 (TOTAL UNITS), MODERATE SCENARIO
TABLE 15 INHALERS MARKET, BY PRODUCT, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO
TABLE 16 INHALERS MARKET, BY PRODUCT, 20142022 (TOTAL UNITS), RAPID SCENARIO
TABLE 17 INHALERS MARKET, BY GEOGRAPHY, 20142022 (TOTAL UNITS), MODERATE SCENARIO
TABLE 18 INHALERS MARKET, BY GEOGRAPHY, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO
TABLE 19 INHALERS MARKET, BY GEOGRAPHY, 20142022 (TOTAL UNITS), RAPID SCENARIO
TABLE 20 DPIS: TYPES
TABLE 21 NEBULIZERS MARKET, BY GEOGRAPHY, 20142022 ($000), MODERATE SCENARIO
TABLE 22 NEBULIZERS MARKET, BY GEOGRAPHY, 20142022 ($000), DIMINISHING SCENARIO
TABLE 23 NEBULIZERS MARKET, BY GEOGRAPHY, 20142022 ($000), RAPID SCENARIO
TABLE 24 NEBULIZERS MARKET, BY GEOGRAPHY, 20142022 (TOTAL UNITS), MODERATE SCENARIO
TABLE 25 NEBULIZERS MARKET, BY GEOGRAPHY, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO
TABLE 26 NEBULIZERS MARKET, BY GEOGRAPHY, 20142022 (TOTAL UNITS), RAPID SCENARIO
TABLE 27 SMART INHALERS MARKET, BY INDICATION, 20142022 ($000), MODERATE SCENARIO
TABLE 28 SMART INHALERS MARKET, BY INDICATION, 20142022 ($000), DIMINISHING SCENARIO
TABLE 29 SMART INHALERS MARKET, BY INDICATION, 20142022 ($000), RAPID SCENARIO
TABLE 30 SMART INHALERS MARKET, BY INDICATION, 20142022 (TOTAL UNITS), MODERATE SCENARIO
TABLE 31 SMART INHALERS MARKET, BY INDICATION, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO
TABLE 32 SMART INHALERS MARKET, BY INDICATION, 20142022 (TOTAL UNITS), RAPID SCENARIO
TABLE 33 SMART INHALERS MARKET FOR ASTHMA, BY GEOGRAPHY, 20142022 ($000), MODERATE SCENARIO
TABLE 34 SMART INHALERS MARKET FOR ASTHMA, BY GEOGRAPHY, 20142022 ($000), DIMINISHING SCENARIO
TABLE 35 SMART INHALERS MARKET FOR ASTHMA, BY GEOGRAPHY, 20142022 ($000), RAPID SCENARIO
TABLE 36 SMART INHALERS MARKET FOR ASTHMA, BY GEOGRAPHY, 20142022 (TOTAL UNITS), MODERATE SCENARIO
TABLE 37 SMART INHALERS MARKET FOR ASTHMA, BY GEOGRAPHY, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO
TABLE 38 SMART INHALERS MARKET FOR ASTHMA, BY GEOGRAPHY, 20142022 (TOTAL UNITS), RAPID SCENARIO
TABLE 39 SMART INHALERS MARKET FOR COPD, BY GEOGRAPHY, 20142022 ($000), MODERATE SCENARIO
TABLE 40 SMART INHALERS MARKET FOR COPD, BY GEOGRAPHY, 20142022 ($000), DIMINISHING SCENARIO
TABLE 41 SMART INHALERS MARKET FOR COPD, BY GEOGRAPHY, 20142022 ($000), RAPID SCENARIO
TABLE 42 SMART INHALERS MARKET FOR COPD, BY GEOGRAPHY, 20142022 (TOTAL UNITS), MODERATE SCENARIO
TABLE 43 SMART INHALERS MARKET FOR COPD, BY GEOGRAPHY, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO
TABLE 44 SMART INHALERS MARKET FOR COPD, BY GEOGRAPHY, 20142022 (TOTAL UNITS), RAPID SCENARIO
TABLE 45 SMART INHALERS MARKET, BY END USER, 20142022 ($000), MODERATE SCENARIO
TABLE 46 SMART INHALERS MARKET, BY END USER, 20142022 ($000), DIMINISHING SCENARIO
TABLE 47 SMART INHALERS MARKET, BY END USER, 20142022 ($000), RAPID SCENARIO
TABLE 48 SMART INHALERS MARKET, BY END USER, 20142022 (TOTAL UNITS), MODERATE SCENARIO
TABLE 49 SMART INHALERS MARKET, BY END USER, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO
TABLE 50 SMART INHALERS MARKET, BY END USER, 20142022 (TOTAL UNITS), RAPID SCENARIO
TABLE 51 SMART INHALERS MARKET FOR PATIENTS, BY GEOGRAPHY, 20142022 ($000), MODERATE SCENARIO
TABLE 52 SMART INHALERS MARKET FOR PATIENTS, BY GEOGRAPHY, 20142022 ($000), DIMINISHING SCENARIO
TABLE 53 SMART INHALERS MARKET FOR PATIENTS, BY GEOGRAPHY, 20142022 ($000), RAPID SCENARIO
TABLE 54 SMART INHALERS MARKET FOR PATIENTS, BY GEOGRAPHY, 20142022 (TOTAL UNITS), MODERATE SCENARIO
TABLE 55 SMART INHALERS MARKET FOR PATIENTS, BY GEOGRAPHY, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO
TABLE 56 SMART INHALERS MARKET FOR PATIENTS, BY GEOGRAPHY, 20142022 (TOTAL UNITS), RAPID SCENARIO
TABLE 57 SMART INHALERS MARKET FOR R&D, BY GEOGRAPHY, 20142022 ($000), MODERATE SCENARIO
TABLE 58 SMART INHALERS MARKET FOR R&D, BY GEOGRAPHY, 20142022 ($000), DIMINISHING SCENARIO
TABLE 59 SMART INHALERS MARKET FOR R&D, BY GEOGRAPHY, 20142022 ($000), RAPID SCENARIO
TABLE 60 SMART INHALERS MARKET FOR R&D, BY GEOGRAPHY, 20142022 (TOTAL UNITS), MODERATE SCENARIO
TABLE 61 SMART INHALERS MARKET FOR R&D, BY GEOGRAPHY, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO
TABLE 62 SMART INHALERS MARKET FOR R&D, BY GEOGRAPHY, 20142022 (TOTAL UNITS), RAPID SCENARIO
TABLE 63 SMART INHALERS MARKET, BY GEOGRAPHY, 20142022 ($000), MODERATE SCENARIO
TABLE 64 SMART INHALERS MARKET, BY GEOGRAPHY, 20142022 ($000), DIMINISHING SCENARIO
TABLE 65 SMART INHALERS MARKET, BY GEOGRAPHY, 20142022 ($000), RAPID SCENARIO
TABLE 66 SMART INHALERS MARKET, BY GEOGRAPHY, 20142022 (TOTAL UNITS), MODERATE SCENARIO
TABLE 67 SMART INHALERS MARKET, BY GEOGRAPHY, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO
TABLE 68 SMART INHALERS MARKET, BY GEOGRAPHY, 20142022 (TOTAL UNITS), RAPID SCENARIO
TABLE 69 NORTH AMERICA: SMART INHALERS MARKET, BY INDICATION, 20142022 ($000), MODERATE SCENARIO
TABLE 70 NORTH AMERICA: SMART INHALERS MARKET, BY INDICATION, 20142022 ($000), DIMINISHING SCENARIO
TABLE 71 NORTH AMERICA: SMART INHALERS MARKET, BY INDICATION, 20142022 ($000), RAPID SCENARIO
TABLE 72 NORTH AMERICA: SMART INHALERS MARKET, BY INDICATION, 20142022 (TOTAL UNITS), MODERATE SCENARIO
TABLE 73 NORTH AMERICA: SMART INHALERS MARKET, BY INDICATION, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO
TABLE 74 NORTH AMERICA: SMART INHALERS MARKET, BY INDICATION, 20142022 (TOTAL UNITS), RAPID SCENARIO
TABLE 75 NORTH AMERICA: SMART INHALERS MARKET, BY END USER, 20142022 ($000), MODERATE SCENARIO
TABLE 76 NORTH AMERICA: SMART INHALERS MARKET, BY END USER, 20142022 ($000), DIMINISHING SCENARIO
TABLE 77 NORTH AMERICA: SMART INHALERS MARKET, BY END USER, 20142022 ($000), RAPID SCENARIO
TABLE 78 NORTH AMERICA: SMART INHALERS MARKET, BY END USER, 20142022 (TOTAL UNITS), MODERATE SCENARIO
TABLE 79 NORTH AMERICA: SMART INHALERS MARKET, BY END USER, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO
TABLE 80 NORTH AMERICA: SMART INHALERS MARKET, BY END USER, 20142022 (TOTAL UNITS), RAPID SCENARIO
TABLE 81 NORTH AMERICA: SMART INHALERS MARKET, BY PRODUCT, 20142022 ($000), MODERATE SCENARIO
TABLE 82 NORTH AMERICA: SMART INHALERS MARKET, BY PRODUCT, 20142022 ($000), DIMINISHING SCENARIO
TABLE 83 NORTH AMERICA: SMART INHALERS MARKET, BY PRODUCT, 20142022 ($000), RAPID SCENARIO
TABLE 84 NORTH AMERICA: SMART INHALERS MARKET, BY PRODUCT, 20142022 (TOTAL UNITS), MODERATE SCENARIO
TABLE 85 NORTH AMERICA: SMART INHALERS MARKET, BY PRODUCT, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO
TABLE 86 NORTH AMERICA: SMART INHALERS MARKET, BY PRODUCT, 20142022 (TOTAL UNITS), RAPID SCENARIO
TABLE 87 NORTH AMERICA: SMART INHALERS MARKET, BY COUNTRY, 20142022 ($000), MODERATE SCENARIO
TABLE 88 NORTH AMERICA: SMART INHALERS MARKET, BY COUNTRY, 20142022 ($000), DIMINISHING SCENARIO
TABLE 89 NORTH AMERICA: SMART INHALERS MARKET, BY COUNTRY, 20142022 ($000), RAPID SCENARIO
TABLE 90 NORTH AMERICA: SMART INHALERS MARKET, BY COUNTRY, 20142022 (TOTAL UNITS), MODERATE SCENARIO
TABLE 91 NORTH AMERICA: SMART INHALERS MARKET, BY COUNTRY, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO
TABLE 92 NORTH AMERICA: SMART INHALERS MARKET, BY COUNTRY, 20142022 (TOTAL UNITS), RAPID SCENARIO
TABLE 93 EUROPE: SMART INHALERS MARKET, BY INDICATION, 20142022 ($000), MODERATE SCENARIO
TABLE 94 EUROPE: SMART INHALERS MARKET, BY INDICATION, 20142022 ($000), DIMINISHING SCENARIO
TABLE 95 EUROPE: SMART INHALERS MARKET, BY INDICATION, 20142022 ($000), RAPID SCENARIO
TABLE 96 EUROPE: SMART INHALERS MARKET, BY INDICATION, 20142022 (TOTAL UNITS), MODERATE SCENARIO
TABLE 97 EUROPE: SMART INHALERS MARKET, BY INDICATION, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO
TABLE 98 EUROPE: SMART INHALERS MARKET, BY INDICATION, 20142022 (TOTAL UNITS), RAPID SCENARIO
TABLE 99 EUROPE: SMART INHALERS MARKET, BY END USER, 20142022 ($000), MODERATE SCENARIO
TABLE 100 EUROPE: SMART INHALERS MARKET, BY END USER, 20142022 ($000), DIMINISHING SCENARIO
TABLE 101 EUROPE: SMART INHALERS MARKET, BY END USER, 20142022 ($000), RAPID SCENARIO
TABLE 102 EUROPE: SMART INHALERS MARKET, BY END USER, 20142022 (TOTAL UNITS), MODERATE SCENARIO
TABLE 103 EUROPE: SMART INHALERS MARKET, BY END USER, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO
TABLE 104 EUROPE: SMART INHALERS MARKET, BY END USER, 20142022 (TOTAL UNITS), RAPID SCENARIO
TABLE 105 EUROPE: SMART INHALERS MARKET, BY PRODUCT, 20142022 ($000), MODERATE SCENARIO
TABLE 106 EUROPE: SMART INHALERS MARKET, BY PRODUCT, 20142022 ($000), DIMINISHING SCENARIO
TABLE 107 EUROPE: SMART INHALERS MARKET, BY PRODUCT, 20142022 ($000), RAPID SCENARIO
TABLE 108 EUROPE: SMART INHALERS MARKET, BY PRODUCT, 20142022 (TOTAL UNITS), MODERATE SCENARIO
TABLE 109 EUROPE: SMART INHALERS MARKET, BY PRODUCT, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO
TABLE 110 EUROPE: SMART INHALERS MARKET, BY PRODUCT, 20142022 (TOTAL UNITS), RAPID SCENARIO
TABLE 111 EUROPE: SMART INHALERS MARKET, BY COUNTRY, 20142022 ($000), MODERATE SCENARIO
TABLE 112 EUROPE: SMART INHALERS MARKET, BY COUNTRY, 20142022 ($000), DIMINISHING SCENARIO
TABLE 113 EUROPE: SMART INHALERS MARKET, BY COUNTRY, 20142022 ($000), RAPID SCENARIO
TABLE 114 EUROPE: SMART INHALERS MARKET, BY COUNTRY, 20142022 (TOTAL UNITS), MODERATE SCENARIO
TABLE 115 EUROPE: SMART INHALERS MARKET, BY COUNTRY, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO
TABLE 116 EUROPE: SMART INHALERS MARKET, BY COUNTRY, 20142022 (TOTAL UNITS), RAPID SCENARIO
TABLE 117 ASIA-PACIFIC: SMART INHALERS MARKET, BY INDICATION, 20142022 ($000), MODERATE SCENARIO
TABLE 118 ASIA-PACIFIC: SMART INHALERS MARKET, BY INDICATION, 20142022 ($000), DIMINISHING SCENARIO
TABLE 119 ASIA-PACIFIC: SMART INHALERS MARKET, BY INDICATION, 20142022 ($000), RAPID SCENARIO
TABLE 120 ASIA-PACIFIC: SMART INHALERS MARKET, BY INDICATION, 20142022 (TOTAL UNITS), MODERATE SCENARIO
TABLE 121 ASIA-PACIFIC: SMART INHALERS MARKET, BY INDICATION, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO
TABLE 122 ASIA-PACIFIC: SMART INHALERS MARKET, BY INDICATION, 20142022 (TOTAL UNITS), RAPID SCENARIO
TABLE 123 ASIA-PACIFIC: SMART INHALERS MARKET, BY END USER, 20142022 ($000), MODERATE SCENARIO
TABLE 124 ASIA-PACIFIC: SMART INHALERS MARKET, BY END USER, 20142022 ($000), DIMINISHING SCENARIO
TABLE 125 ASIA-PACIFIC: SMART INHALERS MARKET, BY END USER, 20142022 ($000), RAPID SCENARIO
TABLE 126 ASIA-PACIFIC: SMART INHALERS MARKET, BY END USER, 20142022 (TOTAL UNITS), MODERATE SCENARIO
TABLE 127 ASIA-PACIFIC: SMART INHALERS MARKET, BY END USER, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO
TABLE 128 ASIA-PACIFIC: SMART INHALERS MARKET, BY END USER, 20142022 (TOTAL UNITS), RAPID SCENARIO
TABLE 129 ASIA-PACIFIC: SMART INHALERS MARKET, BY PRODUCT, 20142022 ($000), MODERATE SCENARIO
TABLE 130 ASIA-PACIFIC: SMART INHALERS MARKET, BY PRODUCT, 20142022 ($000), DIMINISHING SCENARIO
TABLE 131 ASIA-PACIFIC: SMART INHALERS MARKET, BY PRODUCT, 20142022 ($000), RAPID SCENARIO
TABLE 132 ASIA-PACIFIC: SMART INHALERS MARKET, BY PRODUCT, 20142022 (TOTAL UNITS), MODERATE SCENARIO
TABLE 133 ASIA-PACIFIC: SMART INHALERS MARKET, BY PRODUCT, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO
TABLE 134 ASIA-PACIFIC: SMART INHALERS MARKET, BY PRODUCT, 20142022 (TOTAL UNITS), RAPID SCENARIO
TABLE 135 ASIA-PACIFIC: SMART INHALERS MARKET, BY COUNTRY, 20142022 ($000), MODERATE SCENARIO
TABLE 136 ASIA-PACIFIC: SMART INHALERS MARKET, BY COUNTRY, 20142022 ($000), DIMINISHING SCENARIO
TABLE 137 ASIA-PACIFIC: SMART INHALERS MARKET, BY COUNTRY, 20142022 ($000), RAPID SCENARIO
TABLE 138 ASIA-PACIFIC: SMART INHALERS MARKET, BY COUNTRY, 20142022 (TOTAL UNITS), MODERATE SCENARIO
TABLE 139 ASIA-PACIFIC: SMART INHALERS MARKET, BY COUNTRY, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO
TABLE 140 ASIA-PACIFIC: SMART INHALERS MARKET, BY COUNTRY, 20142022 (TOTAL UNITS), RAPID SCENARIO
TABLE 141 LAMEA: SMART INHALERS MARKET, BY INDICATION, 20142022 ($000), MODERATE SCENARIO
TABLE 142 LAMEA: SMART INHALERS MARKET, BY INDICATION, 20142022 ($000), DIMINISHING SCENARIO
TABLE 143 LAMEA: SMART INHALERS MARKET, BY INDICATION, 20142022 ($000), RAPID SCENARIO
TABLE 144 LAMEA: SMART INHALERS MARKET, BY INDICATION, 20142022 (TOTAL UNITS), MODERATE SCENARIO
TABLE 145 LAMEA: SMART INHALERS MARKET, BY INDICATION, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO
TABLE 146 LAMEA: SMART INHALERS MARKET, BY INDICATION, 20142022 (TOTAL UNITS), RAPID SCENARIO
TABLE 147 LAMEA: SMART INHALERS MARKET, BY END USER, 20142022 ($000), MODERATE SCENARIO
TABLE 148 LAMEA: SMART INHALERS MARKET, BY END USER, 20142022 ($000), DIMINISHING SCENARIO
TABLE 149 LAMEA: SMART INHALERS MARKET, BY END USER, 20142022 ($000), RAPID SCENARIO
TABLE 150 LAMEA: SMART INHALERS MARKET, BY END USER, 20142022 (TOTAL UNITS), MODERATE SCENARIO
TABLE 151 LAMEA: SMART INHALERS MARKET, BY END USER, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO
TABLE 152 LAMEA: SMART INHALERS MARKET, BY END USER, 20142022 (TOTAL UNITS), RAPID SCENARIO
TABLE 153 LAMEA: SMART INHALERS MARKET, BY PRODUCT, 20142022 ($000), MODERATE SCENARIO
TABLE 154 LAMEA: SMART INHALERS MARKET, BY PRODUCT, 20142022 ($000), DIMINISHING SCENARIO
TABLE 155 LAMEA: SMART INHALERS MARKET, BY PRODUCT, 20142022 ($000), RAPID SCENARIO
TABLE 156 LAMEA: SMART INHALERS MARKET, BY PRODUCT, 20142022 (TOTAL UNITS), MODERATE SCENARIO
TABLE 157 LAMEA: SMART INHALERS MARKET, BY PRODUCT, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO
TABLE 158 LAMEA: SMART INHALERS MARKET, BY PRODUCT, 20142022 (TOTAL UNITS), RAPID SCENARIO
TABLE 159 LAMEA: SMART INHALERS MARKET, BY COUNTRY, 20142022 ($000), MODERATE SCENARIO
TABLE 160 LAMEA: SMART INHALERS MARKET, BY COUNTRY, 20142022 ($000), DIMINISHING SCENARIO
TABLE 161 LAMEA: SMART INHALERS MARKET, BY COUNTRY, 20142022 ($000), RAPID SCENARIO
TABLE 162 LAMEA: SMART INHALERS MARKET, BY COUNTRY, 20142022 (TOTAL UNITS), MODERATE SCENARIO
TABLE 163 LAMEA: SMART INHALERS MARKET, BY COUNTRY, 20142022 (TOTAL UNITS), DIMINISHING SCENARIO
TABLE 164 LAMEA: SMART INHALERS MARKET, BY COUNTRY, 20142022 (TOTAL UNITS), RAPID SCENARIO
TABLE 165 ADHERIUM: COMPANY SNAPSHOT
TABLE 166 ADHERIUM: OPERATING SEGMENTS
TABLE 167 TEVA: COMPANY SNAPSHOT
TABLE 168 TEVA: OPERATING SEGMENTS
TABLE 169 PROPELLER HEALTH: COMPANY SNAPSHOT
TABLE 170 PROPELLER HEALTH: OPERATING SEGMENTS
TABLE 171 COHERO HEALTH: COMPANY SNAPSHOT
TABLE 172 COHERO HEALTH: OPERATING SEGMENTS
TABLE 173 OPKO HEALTH: COMPANY SNAPSHOT
TABLE 174 OPKO HEALTH: OPERATING SEGMENTS
TABLE 175 GSK: COMPANY SNAPSHOT
TABLE 176 GSK: OPERATING SEGMENTS
TABLE 177 NOVARTIS: COMPANY SNAPSHOT
TABLE 178 NOVARTIS: OPERATING SEGMENTS
TABLE 179 ASTRAZENECA: COMPANY SNAPSHOT
TABLE 180 ASTRAZENECA: OPERATING SEGMENTS
TABLE 181 BOEHRINGER INGELHEIM: COMPANY SNAPSHOT
TABLE 182 BOEHRINGER INGELHEIM: OPERATING SEMENTS
TABLE 183 VECTURA: COMPANY SNAPSHOT
TABLE 184 VECTURA: OPERATING SEGMENTS

PURCHASE OPTIONS
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter

 
 

Related Reports

Global Hematology Analyzer Sale, Insights Market Research Report 2019-2025

Published On : December   2019

$ 3600

Global Dental Handpiece Sale, Insights Market Research Report 2019-2025

Published On : December   2019

$ 3600

Global MRI (Magnetic Resonance Imaging System) Sale, Insights Market Research Report 2019-2025

Published On : December   2019

$ 3600

Global Defibrillator Sale, Insights Market Research Report 2019-2025

Published On : December   2019

$ 3600

Global Anesthesia Video Laryngoscope Sale, Insights Market Research Report 2019-2025

Published On : December   2019

$ 3600

Global Emergency Ambulance Sale, Insights Market Research Report 2019-2025

Published On : December   2019

$ 3600

REQUEST SAMPLE    ASK FOR DISCOUNT